Original Research
Published on 10 Feb 2023
Pharmacovigilance on cannabidiol as an antiepileptic agent
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1091978
- 5,494 views
- 23 citations
25 articles related to "Eudravigilance"
Articles
Original Research
Accepted on 21 Apr 2026
A 'One Health' Cross-Sectional Analysis of Reports of Potential Antibiotic Resistance Cases in International Pharmacovigilance Databases
in Infectious Diseases: Epidemiology and Prevention
Frontiers in Public Health
- 208 views
Original Research
Published on 09 Jan 2026
Gender and age variations in neuropsychiatric adverse events of cetirizine and levocetirizine: a disproportionality analysis of ICSRs from FAERS and EudraVigilance data
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1737359
- 1,812 views
Original Research
Accepted on 27 Apr 2026
A Comparison of Antibiotic Resistance Reports in Pharmacovigilance Databases to Conventional Surveillance Across 'One Health'
in Infectious Diseases: Epidemiology and Prevention
Frontiers in Public Health
- 162 views
Original Research
Published on 06 Apr 2023
Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1130636
- 5,317 views
- 10 citations
Original Research
Published on 29 Apr 2026
Unmasking counterfeit semaglutide: analysis of real-world safety data from EudraVigilance
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1805842
- 442 views
Original Research
Published on 02 Dec 2020
We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database
in Child and Adolescent Psychiatry
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.550201
- 11,670 views
- 17 citations
Original Research
Accepted on 09 Apr 2026
Pharmacovigilance Analysis of Cutaneous Adverse Drug Reactions for Cetuximab, Panitumumab, and Necitumumab Based on EudraVigilance and WHO VigiAccess
in Pharmacoepidemiology
Frontiers in Pharmacology
- 239 views
Original Research
Published on 06 Sep 2022
Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.964399
- 12,678 views
- 34 citations
Mini Review
Published on 29 Sep 2022
Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based COVID-19 vaccines
in Thrombosis and Haemostasis
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.967926
- 4,760 views
- 11 citations
Original Research
Published on 24 Jul 2024
Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411134
- 3,799 views
- 4 citations
Original Research
Published on 29 Mar 2022
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.844122
- 5,367 views
- 10 citations
Original Research
Published on 13 Sep 2022
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.956825
- 12,047 views
- 22 citations
Original Research
Published on 29 Jan 2026
Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1765071
- 2,088 views
- 2 citations
Original Research
Published on 09 Jan 2026
Hepatobiliary adverse drug reactions during treatment with olaparib: an analysis of data from the EudraVigilance reporting system
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1736759
- 1,265 views
- 1 citation
Original Research
Published on 22 Jan 2026
Differential musculoskeletal outcome reporting in patients receiving bempedoic acid or atorvastatin: a disproportionality analysis using the EudraVigilance database
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1736657
- 1,350 views